Get the Stockscreener App
3.5373
3.09%
-0.1127
After Hours:
3.54
0.00273
+0.08%
Universe Pharmaceuticals Inc stock is traded at $3.5373, with a volume of 27,779.
It is down -3.09% in the last 24 hours and down -5.67% over the past month.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
See More
Previous Close:
$3.65
Open:
$3.75
24h Volume:
27,779
Relative Volume:
0.13
Market Cap:
$1.81M
Revenue:
$32.31M
Net Income/Loss:
$-6.16M
P/E Ratio:
-2.0807
EPS:
-1.7
Net Cash Flow:
$1.08M
1W Performance:
-3.36%
1M Performance:
-5.67%
6M Performance:
-78.17%
1Y Performance:
-99.84%
1-Day Range:
$3.53
$3.844
1-Week Range:
$3.40
$5.18
52-Week Range:
$2.51
$2,370.00
Universe Pharmaceuticals Inc Stock (UPC) Company Profile
Compare UPC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
UPC
Universe Pharmaceuticals Inc
|
3.5373 | 2.06M | 32.31M | -6.16M | 1.08M | -1.70 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Universe Pharmaceuticals Inc Stock (UPC) Latest News
When is the best time to exit Universe Pharmaceuticals INCBuy Entry Confirmation Based on Technical Analysis - Newser
Universe Pharmaceuticals INC Shows Risk Reward Favoring UpsideVolume Based Entry Signal Plan - beatles.ru
Sectors Driving Future Growth for Universe Pharmaceuticals INC StockProfitable Trading Blueprint with Entry Zones - Newser
Can machine learning forecast Universe Pharmaceuticals INC recoveryFast Entry Strategy with Price Prediction - Newser
Published on: 2025-07-31 00:19:28 - Newser
Measuring Universe Pharmaceuticals INC’s beta against major indicesEquity Portfolio Outlook and Performance Summary - Newser
Is Universe Pharmaceuticals INC a candidate for recovery playFree Alert Feed for Momentum Based Picks - Newser
Real time social sentiment graph for Universe Pharmaceuticals INCSwing Gain Strategy with Entry Forecast - Newser
Reversal indicators forming on Universe Pharmaceuticals INC stockSwing Reversal Forecast Based on Patterns - Newser
Universe Pharmaceuticals INC stock chart pattern explainedStock Holding Strategy Long-Term Summary Sheet - Newser
Published on: 2025-07-29 16:22:32 - Newser
Universe Pharmaceuticals announces 2025 annual general meeting materials By Investing.com - Investing.com Nigeria
Universe Pharmaceuticals announces 2025 annual general meeting materials - Investing.com
Universe Pharmaceuticals Announces 2025 AGM and Major Capital Reorganization - TipRanks
Published on: 2025-07-29 15:00:53 - metal.it
Is now a turning point for Universe Pharmaceuticals INCTactical Trade Setup With Entry Optimizer - Newser
Is Universe Pharmaceuticals INC Stock Overbought or Oversold RSI Indicator AnalysisReal-Time Entry Forecast with Accuracy Metrics - Newser
Why Universe Pharmaceuticals INC stock attracts strong analyst attentionFree Smart Trend Trading with Weekly Signals - Newser
How Universe Pharmaceuticals INC stock performs during market volatilityFree Low Risk Equity Screener With Results - Newser
What catalysts could drive Universe Pharmaceuticals INC stock higher in 2025Free Stock Market Trend Analysis - jammulinksnews.com
How does Universe Pharmaceuticals INC generate profit in a changing economyHigh-velocity capital appreciation - jammulinksnews.com
How many analysts rate Universe Pharmaceuticals INC as a “Buy”Unlock daily market insights for better decisions - jammulinksnews.com
Should I hold or sell Universe Pharmaceuticals INC stock in 2025Free Stock Market Real-Time Monitoring - jammulinksnews.com
Is it the right time to buy Universe Pharmaceuticals INC stockBuild wealth steadily with proven methods - jammulinksnews.com
How Efficient Is Universe Pharmaceuticals INC at Controlling Operating CostsSteady Profit Stock Forecasts - metal.it
Is Universe Pharmaceuticals INC a good long term investmentSuperior profit margins - PrintWeekIndia
What drives CIIT stock pricePowerful profit generation - PrintWeekIndia
The Future of India’s Consumer Goods Market and Stocks Exclusive Investor Stock PicksStrong return on assets - PrintWeekIndia
Universe Pharmaceuticals INC Stock Analysis and ForecastHigh-yield capital appreciation - PrintWeekIndia
What makes NXDT.PRA stock price move sharplyFree Stock Investment Growth Plan - Newser
What drives Universe Pharmaceuticals INC stock priceExceptional profit potential - PrintWeekIndia
What analysts say about Tvardi Therapeutics Inc. stockSuperior investment outcomes - Autocar Professional
TruBridge Inc. Stock Analysis and ForecastUnmatched market performance - jammulinksnews.com
Best Technology Stocks AI Powered Stock InsightsFree Stock Index Interpretation - Autocar Professional
JTL Industries Limited (534600) Sees Unusual Trading VolumeRapidly expanding wealth - jammulinksnews.com
Would You Accumulate or Wait on Trident Limited (521064)Skyrocketing profit margins - Autocar Professional
Top Performing Stocks on the NSE in India Expert Chosen Financial InsightsFree Risk Assessment Services - Autocar Professional
What analysts say about Universe Pharmaceuticals INC stockRapid wealth multiplication - jammulinksnews.com
Universe Pharmaceuticals Inc Stock (UPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):